Lisen Arnheim Dahlström

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

* 1999 Kandidatexamen i biomedicin med mikrobiologi som huvudämne,
Manchester Metropolitan University, England
* 2005 Doktorsexamen i Smittskydd, Karolinska Institutet

Forskningsbeskrivning

Min forskning fokuserar främst på att förbättra metoder för att
förebygga livmoderhalscancer och att utvärdera vacciners säkerhet och
effektivitet.

Artiklar

Article: SUPPORTIVE CARE IN CANCER. 2022;30(11):9101-9108

Patients' perspectives on the effect of the COVID-19 pandemic on access to cancer care and social contacts in Sweden and the UK: a cross-sectional study.

Edlund K; Dahlström LA; Ekström AM; van der Kop ML
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2022;118:34-43

Severity of the clinical presentation of hepatitis A in five European countries from 1995 to 2014.

Severi E; Georgalis L; Pijnacker R; Veneti L; Turiac IA; Chiesa F; Rizzo C; Martinelli D; Vold L; Herrador BG; Martinez CV; Sanchez EVM; Semenza JC; Lopalco P; Dahlström LA; Giesecke J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;107(1):63-73

The impact of changed treatment patterns in multiple myeloma on health-care utilisation and costs, myeloma complications, and survival: A population-based comparison between two time periods in Denmark.

Hannig LH; Nielsen LK; Ibsen R; Arnheim-Dahlström L; Kjellberg J; Abildgaard N
Article: PLOS ONE. 2021;16(10):e0256642

Parental acceptance and knowledge of varicella vaccination in relation to socioeconomics in Sweden: A cross-sectional study.

Arnheim-Dahlström L; Zarabi N; Hagen K; Bencina G
Article: VACCINE. 2020;38 Suppl 2:B31-B37

Advance system testing: Vaccine benefit studies using multi-country electronic health data - The example of pertussis vaccination.

Tin Tin Htar M; de Ridder M; Braeye T; Correa A; McGee C; de Lusignan S; Duarte-Salles T; Huerta-Alvarez C; Martín-Merino E; Tramontan L; Danieli G; Picelli G; van der Maas N; Berencsi K; Arnheim-Dahlström L; Heininger U; Emborg H-D; Weibel D; Bollaerts K; Sturkenboom M
Article: PREVENTIVE MEDICINE. 2020;131:105944

Factors associated with condom use during sexual intercourse with a new partner among Scandinavian women.

Tatla MK; Faber MT; Hansen BT; Arnheim-Dahlström L; Munk C; Nygård M; Kjær SK
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2020;99(2):175-185

Age at first intercourse, number of partners and sexually transmitted infection prevalence among Danish, Norwegian and Swedish women: estimates and trends from nationally representative cross-sectional surveys of more than 100 000 women.

Hansen BT; Kjaer SK; Arnheim-Dahlström L; Liaw K-L; Juul KE; Thomsen LT; Frederiksen K; Elfström KM; Munk C; Nygård M
Article: RESPIRATORY MEDICINE. 2019;155:72-78

Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015.

Sköld CM; Arnheim-Dahlström L; Bartley K; Janson C; Kirchgaessler K-U; Levine A; Ferrara G
Article: VACCINE. 2019;37(31):4401-4406

Effectiveness of the herpes zoster vaccine Zostavax® in Stockholm County, Sweden.

Blom K; Yin L; Arnheim-Dahlström L
Article: PULMONARY THERAPY. 2019;5(1):55-68

Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden.

Ferrara G; Arnheim-Dahlström L; Bartley K; Janson C; Kirchgässler K-U; Levine A; Sköld CM
Article: CONTRACEPTION. 2019;99(4):217-221

Contraceptive use at first intercourse is associated with subsequent sexual behaviors.

Guleria S; Thomsen LT; Munk C; Nygård M; Hansen BT; Elfström KM; Arnheim-Dahlström L; Liaw K-L; Frederiksen K; Kjær SK
Article: PREVENTIVE MEDICINE. 2019;120:26-33

Mode of HPV vaccination delivery and equity in vaccine uptake: A nationwide cohort study.

Wang J; Ploner A; Sparén P; Lepp T; Roth A; Arnheim-Dahlström L; Sundström K
Article: SEXUALLY TRANSMITTED INFECTIONS. 2018;94(7):522-527

Self-perceived risk of STIs in a population-based study of Scandinavian women.

Guleria S; Faber MT; Hansen BT; Arnheim-Dahlström L; Liaw K-L; Munk C; Nygård M; Kjær SK
Article: VACCINE. 2018;36(43):6373-6378

Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.

Dehlendorff C; Sparén P; Baldur-Felskov B; Herweijer E; Arnheim-Dahlström L; Ploner A; Uhnoo I; Kjaer SK
Article: VACCINE. 2018;36(41):6202-6211

Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.

Weibel D; Sturkenboom M; Black S; de Ridder M; Dodd C; Bonhoeffer J; Vanrolleghem A; van der Maas N; Lammers GJ; Overeem S; Gentile A; Giglio N; Castellano V; Kwong JC; Murray BJ; Cauch-Dudek K; Juhasz D; Campitelli M; Datta AN; Kallweit U; Huang W-T; Huang Y-S; Hsu C-Y; Chen H-C; Giner-Soriano M; Morros R; Gaig C; Tió E; Perez-Vilar S; Diez-Domingo J; Puertas FJ; Svenson LW; Mahmud SM; Carleton B; Naus M; Arnheim-Dahlström L; Pedersen L; DeStefano F; Shimabukuro TT
Article: JOURNAL OF INTERNAL MEDICINE. 2018;283(2):154-165

Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases.

Hviid A; Svanström H; Scheller NM; Grönlund O; Pasternak B; Arnheim-Dahlström L
Article: PLOS ONE. 2018;13(10):e0204799

Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study.

Dodd CN; de Ridder M; Huang W-T; Weibel D; Giner-Soriano M; Perez-Vilar S; Diez-Domingo J; Svenson LW; Mahmud SM; Carleton B; Naus M; Kwong JC; Murray BJ; Arnheim-Dahlstrom L; Pedersen L; Morros R; Puertas FJ; Black S; Sturkenboom M
Article: VIRAL IMMUNOLOGY. 2017;30(8):590-600

Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls.

Lind A; Freyhult E; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Lima Bomfim I; Fink K; Fex M; Törn C; Elding Larsson H; Lernmark Å
Article: BMJ OPEN. 2017;7(6):e015021

Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study.

Lamb F; Herweijer E; Ploner A; Uhnoo I; Sundström K; Sparén P; Arnheim-Dahlström L
Article: EUROPEAN JOURNAL OF CANCER PREVENTION. 2017;26(2):170-178

Awareness of human papillomavirus after introduction of HPV vaccination: a large population-based survey of Scandinavian women.

Thomsen LT; Nygård M; Stensen S; Terning Hansen B; Arnheim Dahlström L; Liaw K-L; Munk C; Kjaer SK
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2017;96(3):286-294

Contraceptive non-use and emergency contraceptive use at first sexual intercourse among nearly 12 000 Scandinavian women.

Guleria S; Juul KE; Munk C; Hansen BT; Arnheim-Dahlström L; Liaw K-L; Nygård M; Kjaer SK
Article: GENES AND IMMUNITY. 2017;18(2):75-81

The immunogenetics of narcolepsy associated with A(H1N1)pdm09 vaccination (Pandemrix) supports a potent gene-environment interaction.

Bomfim IL; Lamb F; Fink K; Szakács A; Silveira A; Franzén L; Azhary V; Maeurer M; Feltelius N; Darin N; Hallböök T; Arnheim-Dahlström L; Kockum I; Olsson T
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2017;216(3):264.e1-264.e7

Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial.

Elfgren K; Elfström KM; Naucler P; Arnheim-Dahlström L; Dillner J
Article: JOURNAL OF INTERNAL MEDICINE. 2016;280(6):618-626

Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study.

Grönlund O; Herweijer E; Sundström K; Arnheim-Dahlström L
Article: AUTOIMMUNITY. 2016;49(6):421-433

Autoantibody targets in vaccine-associated narcolepsy.

Häggmark-Månberg A; Zandian A; Forsström B; Khademi M; Lima Bomfim I; Hellström C; Arnheim-Dahlström L; Hallböök T; Darin N; Lundberg IE; Uhlén M; Partinen M; Schwenk JM; Olsson T; Nilsson P
Article: BMC INFECTIOUS DISEASES. 2016;16(1):419

Sexually transmitted infections after bereavement - a population-based cohort study.

Bond E; Lu D; Herweijer E; Sundström K; Valdimarsdóttir U; Fall K; Arnheim-Dahlström L; Sparén P; Fang F
Article: INTERNATIONAL JOURNAL OF CANCER. 2016;138(12):2867-2874

Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.

Herweijer E; Sundström K; Ploner A; Uhnoo I; Sparén P; Arnheim-Dahlström L
Article: BMJ-BRITISH MEDICAL JOURNAL. 2016;352:i276

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.

Wang J; Andrae B; Sundström K; Ström P; Ploner A; Elfström KM; Arnheim-Dahlström L; Dillner J; Sparén P
Article: PLOS ONE. 2016;11(4):e0154296

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination.

Lamb F; Ploner A; Fink K; Maeurer M; Bergman P; Piehl F; Weibel D; Sparén P; Dahlström LA
Article: BMC INFECTIOUS DISEASES. 2015;15:488

Incidence of herpes zoster and associated events including stroke--a population-based cohort study.

Sundström K; Weibull CE; Söderberg-Löfdal K; Bergström T; Sparén P; Arnheim-Dahlström L
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2015;107(10):djv185

Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer.

Sundström K; Ploner A; Arnheim-Dahlström L; Eloranta S; Palmgren J; Adami H-O; Ylitalo Helm N; Sparén P; Dillner J
Article: JOURNAL OF INTERNAL MEDICINE. 2015;278(3):264-276

Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases.

Ambati A; Poiret T; Svahn B-M; Valentini D; Khademi M; Kockum I; Lima I; Arnheim-Dahlström L; Lamb F; Fink K; Meng Q; Kumar A; Rane L; Olsson T; Maeurer M
Article: EUROPEAN JOURNAL OF CANCER. 2015;51(8):950-968

Cervical cancer screening in Europe: Quality assurance and organisation of programmes.

Elfström KM; Arnheim-Dahlström L; von Karsa L; Dillner J
Article: VACCINE. 2015;33(14):1673-1681

Organization and quality of HPV vaccination programs in Europe.

Elfström KM; Dillner J; Arnheim-Dahlström L
Article: INTERNATIONAL JOURNAL OF CANCER. 2015;136(5):1171-1180

Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.

Smelov V; Elfström KM; Johansson ALV; Eklund C; Naucler P; Arnheim-Dahlström L; Dillner J
Article: INTERNATIONAL JOURNAL OF CANCER. 2015;136(2):350-359

Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial.

Elfström KM; Smelov V; Johansson ALV; Eklund C; Naucler P; Arnheim-Dahlström L; Dillner J
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2015;313(1):54-61

Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.

Scheller NM; Svanström H; Pasternak B; Arnheim-Dahlström L; Sundström K; Fink K; Hviid A
Article: PLOS ONE. 2015;10(7):e0134185

The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study.

Herweijer E; Feldman AL; Ploner A; Arnheim-Dahlström L; Uhnoo I; Netterlid E; Dillner J; Sparén P; Sundström K
Article: VACCINE. 2014;32(39):4945-4953

Human papillomavirus (HPV) vaccination and subsequent sexual behaviour: evidence from a large survey of Nordic women.

Hansen BT; Kjær SK; Arnheim-Dahlström L; Liaw K-L; Jensen KE; Thomsen LT; Munk C; Nygård M
Article: JOURNAL OF AUTOIMMUNITY. 2014;50:99-106

A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.

Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson A-L; Bomfim IL; Fink K; Lernmark Å
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2014;311(6):597-603

Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.

Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
Article: BMJ-BRITISH MEDICAL JOURNAL. 2014;348:g130

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.

Elfström KM; Smelov V; Johansson ALV; Eklund C; Nauclér P; Arnheim-Dahlström L; Dillner J
Article: PLOS ONE. 2014;9(1):e82222

Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.

Romio S; Weibel D; Dieleman JP; Olberg HK; de Vries CS; Sammon C; Andrews N; Svanström H; Mølgaard-Nielsen D; Hviid A; Lapeyre-Mestre M; Sommet A; Saussier C; Castot A; Heijbel H; Arnheim-Dahlström L; Sparen P; Mosseveld M; Schuemie M; van der Maas N; Jacobs BC; Leino T; Kilpi T; Storsaeter J; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MCJM
Article: BMJ-BRITISH MEDICAL JOURNAL. 2013;347:f5906

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.

Arnheim-Dahlström L; Pasternak B; Svanström H; Sparén P; Hviid A
Article: VACCINE. 2013;31(40):4448-4458

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.

Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H; Global H1N1 GBS Consortium
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2013;105(7):469-474

Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.

Leval A; Herweijer E; Ploner A; Eloranta S; Fridman Simard J; Dillner J; Young C; Netterlid E; Sparén P; Arnheim-Dahlström L
Article: VACCINE. 2013;31(8):1246-1254

The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns.

Wijnans L; Lecomte C; de Vries C; Weibel D; Sammon C; Hviid A; Svanström H; Mølgaard-Nielsen D; Heijbel H; Dahlström LA; Hallgren J; Sparen P; Jennum P; Mosseveld M; Schuemie M; van der Maas N; Partinen M; Romio S; Trotta F; Santuccio C; Menna A; Plazzi G; Moghadam KK; Ferro S; Lammers GJ; Overeem S; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MCJM
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2013;22(1):150-158

Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical cancer.

Sundström K; Ploner A; Dahlström LA; Palmgren J; Dillner J; Adami H-O; Ylitalo N; Sparén P
Article: BMJ-BRITISH MEDICAL JOURNAL. 2012;345:e7594

Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study.

Arnheim-Dahlström L; Hällgren J; Weibull CE; Sparén P
Article: JOURNAL OF INFECTIOUS DISEASES. 2012;206(6):860-866

Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.

Leval A; Herweijer E; Arnheim-Dahlström L; Walum H; Frans E; Sparén P; Simard JF
Article: VACCINE. 2012;30(19):3042-3046

A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark.

Andrews N; Stowe J; Miller E; Svanström H; Johansen K; Bonhoeffer J; Hviid A; VAESCO consortium
Article: JOURNAL OF ADOLESCENT HEALTH. 2012;50(2):204-206

Awareness and knowledge of human papillomavirus in the Swedish adult population.

Dahlström LA; Sundström K; Young C; Lundholm C; Sparén P; Tran TN
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2011;20(12):2541-2550

Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.

Arnheim Dahlström L; Andersson K; Luostarinen T; Thoresen S; Ögmundsdottír H; Tryggvadottír L; Wiklund F; Skare GB; Eklund C; Sjölin K; Jellum E; Koskela P; Wadell G; Lehtinen M; Dillner J
Article: BMJ-BRITISH MEDICAL JOURNAL. 2011;343:d3908

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.

Dieleman J; Romio S; Johansen K; Weibel D; Bonhoeffer J; Sturkenboom M; VAESCO-GBS Case-Control Study Group
Article: PLOS ONE. 2011;6(6):e20624

Assessing perceived risk and STI prevention behavior: a national population-based study with special reference to HPV.

Leval A; Sundström K; Ploner A; Dahlström LA; Widmark C; Sparén P
Article: VACCINE. 2010;28(47):7492-7500

Acceptability of HPV vaccination among young adults aged 18-30 years--a population based survey in Sweden.

Sundström K; Tran TN; Lundholm C; Young C; Sparén P; Dahlström LA
Article: INTERNATIONAL JOURNAL OF CANCER. 2010;127(8):1923-1930

Prospective study of human papillomavirus and risk of cervical adenocarcinoma.

Dahlström LA; Ylitalo N; Sundström K; Palmgren J; Ploner A; Eloranta S; Sanjeevi CB; Andersson S; Rohan T; Dillner J; Adami H-O; Sparén P
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2010;19(10):2469-2478

Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix.

Sundström K; Eloranta S; Sparén P; Arnheim Dahlström L; Gunnell A; Lindgren A; Palmgren J; Ploner A; Sanjeevi CB; Melbye M; Dillner J; Adami H-O; Ylitalo N
Article: INTERNATIONAL JOURNAL OF CANCER. 2010;126(2):500-507

Attitudes to HPV vaccination among parents of children aged 12-15 years-a population-based survey in Sweden.

Dahlström LA; Tran TN; Lundholm C; Young C; Sundström K; Sparén P
Article: INTERNATIONAL JOURNAL OF CANCER. 2005;116(1):110-115

Chlamydia trachomatis infection and persistence of human papillomavirus.

Silins I; Ryd W; Strand A; Wadell G; Törnberg S; Hansson BG; Wang X; Arnheim L; Dahl V; Bremell D; Persson K; Dillner J; Rylander E
Article: HLA. 2005;65(3):252-259

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

Arnheim L; Dillner J; Sanjeevi CB
Article: VIROLOGY. 2004;322(1):182-189

HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses.

Rollman E; Arnheim L; Collier B; Oberg D; Hall H; Klingström J; Dillner J; Pastrana DV; Buck CB; Hinkula J; Wahren B; Schwartz S
Visa fler

Alla övriga publikationer

Review: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27(11):1159-1165

Differential uptake of herpes zoster vaccination associated with socioeconomic status: A population-based study in Stockholm County, Sweden.

Fogelberg S; Lamb F; Grönlund O; Eriksson I; Sundström K; Clements M; Arnheim-Dahlström L
Letter: JOURNAL OF INTERNAL MEDICINE. 2017;281(3):311-312

Authors' response: Letter to the Editor - HPV vaccine and autoimmunity.

Grönlund O; Herweijer E; Sundström K; Arnheim-Dahlström L
Review: JOURNAL OF INTERNAL MEDICINE. 2015;278(4):335-353

A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden.

Feltelius N; Persson I; Ahlqvist-Rastad J; Andersson M; Arnheim-Dahlström L; Bergman P; Granath F; Adori C; Hökfelt T; Kühlmann-Berenzon S; Liljeström P; Maeurer M; Olsson T; Örtqvist Å; Partinen M; Salmonson T; Zethelius B
Letter: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2014;311(23):2439-2440

Number of human papillomavirus vaccine doses and condyloma--reply.

Ploner A; Herweijer E; Arnheim-Dahlström L
Review: CURRENT OPINION IN ONCOLOGY. 2014;26(1):120-129

Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review.

Elfström KM; Herweijer E; Sundström K; Arnheim-Dahlström L

Anställningar

Anknuten till Forskning, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2022-2024

Examina och utbildning

Docent, epidemiologi, Karolinska Institutet, 2013
MEDICINE DOKTORSEXAMEN, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2005

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI